Impairment of endothelium-dependent dilatation of cerebral arterioles during diabetes mellitus

Research output: Contribution to journalArticle

135 Citations (Scopus)

Abstract

The goal of this study was to determine whether responses of cerebral arterioles to vasoactive substances released by platelets are altered during diabetes mellitus. To induce diabetes, rats were injected with streptozotocin (50-60 mg/kg ip). Rats were characterized as diabetic by a blood glucose of >300 mg/dl. Diameter of pial arterioles was measured during superfusion with ADP, serotonin, and the thromboxane analogue (U-46619), with the use of intravital microscopy in control (non-diabetic) and diabetic rats. ADP (10-5 M) increased pial arteriolar diameter by 13 ± 1% (mean ± SE) in control rats and did not change diameter of arterioles in diabetic rats (1 ± 1%). Serotonin (10-5 M) increased diameter of cerebral arterioles by 9 ± 1% in control rats and constricted arterioles by 5 ± 2% in diabetic rats. Nitroglycerin produced similar dilatation of cerebral arterioles in control and diabetic rats, suggesting that impaired dilatation of cerebral arterioles in diabetic rats was not related to nonspecific impairment of vasodilatation. The thromboxane analogue U-46619 produced similar constriction of cerebral arterioles in control and diabetic rats. Thus endothelium-dependent dilatation of cerebral arteries in response to ADP and serotonin is profoundly impaired in diabetic rats.

Original languageEnglish (US)
Pages (from-to)25/3
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume256
Issue number3
StatePublished - Jan 1 1989

Fingerprint

Arterioles
Endothelium
Dilatation
Diabetes Mellitus
Adenosine Diphosphate
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
Serotonin
Thromboxanes
Cerebral Arteries
Nitroglycerin
Streptozocin
Constriction
Vasodilation
Blood Glucose
Blood Platelets

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

@article{fcea16d993ef42eda40ad14ba8c3f574,
title = "Impairment of endothelium-dependent dilatation of cerebral arterioles during diabetes mellitus",
abstract = "The goal of this study was to determine whether responses of cerebral arterioles to vasoactive substances released by platelets are altered during diabetes mellitus. To induce diabetes, rats were injected with streptozotocin (50-60 mg/kg ip). Rats were characterized as diabetic by a blood glucose of >300 mg/dl. Diameter of pial arterioles was measured during superfusion with ADP, serotonin, and the thromboxane analogue (U-46619), with the use of intravital microscopy in control (non-diabetic) and diabetic rats. ADP (10-5 M) increased pial arteriolar diameter by 13 ± 1{\%} (mean ± SE) in control rats and did not change diameter of arterioles in diabetic rats (1 ± 1{\%}). Serotonin (10-5 M) increased diameter of cerebral arterioles by 9 ± 1{\%} in control rats and constricted arterioles by 5 ± 2{\%} in diabetic rats. Nitroglycerin produced similar dilatation of cerebral arterioles in control and diabetic rats, suggesting that impaired dilatation of cerebral arterioles in diabetic rats was not related to nonspecific impairment of vasodilatation. The thromboxane analogue U-46619 produced similar constriction of cerebral arterioles in control and diabetic rats. Thus endothelium-dependent dilatation of cerebral arteries in response to ADP and serotonin is profoundly impaired in diabetic rats.",
author = "Mayhan, {W. G.}",
year = "1989",
month = "1",
day = "1",
language = "English (US)",
volume = "256",
pages = "25/3",
journal = "American Journal of Physiology - Renal Physiology",
issn = "0363-6127",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - Impairment of endothelium-dependent dilatation of cerebral arterioles during diabetes mellitus

AU - Mayhan, W. G.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - The goal of this study was to determine whether responses of cerebral arterioles to vasoactive substances released by platelets are altered during diabetes mellitus. To induce diabetes, rats were injected with streptozotocin (50-60 mg/kg ip). Rats were characterized as diabetic by a blood glucose of >300 mg/dl. Diameter of pial arterioles was measured during superfusion with ADP, serotonin, and the thromboxane analogue (U-46619), with the use of intravital microscopy in control (non-diabetic) and diabetic rats. ADP (10-5 M) increased pial arteriolar diameter by 13 ± 1% (mean ± SE) in control rats and did not change diameter of arterioles in diabetic rats (1 ± 1%). Serotonin (10-5 M) increased diameter of cerebral arterioles by 9 ± 1% in control rats and constricted arterioles by 5 ± 2% in diabetic rats. Nitroglycerin produced similar dilatation of cerebral arterioles in control and diabetic rats, suggesting that impaired dilatation of cerebral arterioles in diabetic rats was not related to nonspecific impairment of vasodilatation. The thromboxane analogue U-46619 produced similar constriction of cerebral arterioles in control and diabetic rats. Thus endothelium-dependent dilatation of cerebral arteries in response to ADP and serotonin is profoundly impaired in diabetic rats.

AB - The goal of this study was to determine whether responses of cerebral arterioles to vasoactive substances released by platelets are altered during diabetes mellitus. To induce diabetes, rats were injected with streptozotocin (50-60 mg/kg ip). Rats were characterized as diabetic by a blood glucose of >300 mg/dl. Diameter of pial arterioles was measured during superfusion with ADP, serotonin, and the thromboxane analogue (U-46619), with the use of intravital microscopy in control (non-diabetic) and diabetic rats. ADP (10-5 M) increased pial arteriolar diameter by 13 ± 1% (mean ± SE) in control rats and did not change diameter of arterioles in diabetic rats (1 ± 1%). Serotonin (10-5 M) increased diameter of cerebral arterioles by 9 ± 1% in control rats and constricted arterioles by 5 ± 2% in diabetic rats. Nitroglycerin produced similar dilatation of cerebral arterioles in control and diabetic rats, suggesting that impaired dilatation of cerebral arterioles in diabetic rats was not related to nonspecific impairment of vasodilatation. The thromboxane analogue U-46619 produced similar constriction of cerebral arterioles in control and diabetic rats. Thus endothelium-dependent dilatation of cerebral arteries in response to ADP and serotonin is profoundly impaired in diabetic rats.

UR - http://www.scopus.com/inward/record.url?scp=0024596673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024596673&partnerID=8YFLogxK

M3 - Article

C2 - 2923230

AN - SCOPUS:0024596673

VL - 256

SP - 25/3

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 0363-6127

IS - 3

ER -